End-of-day quote
Other stock markets
|
||
- NZD | - |
|
06-20 | Australia shares end flat as tech, healthcare losses offset commodity gains (June 20) | RE |
06-13 | Xero Issues $925 Million of Convertible Notes Due 2031 in Singapore | MT |
Sales 2025 * | 2.08B 1.27B 1.73B | Sales 2026 * | 2.43B 1.49B 2.03B | Capitalization | 22.04B 13.48B 18.41B |
---|---|---|---|---|---|
Net income 2025 * | 272M 166M 227M | Net income 2026 * | 366M 224M 306M | EV / Sales 2025 * | 9.57 x |
Net cash position 2025 * | 2.18B 1.33B 1.82B | Net cash position 2026 * | 1.94B 1.19B 1.62B | EV / Sales 2026 * | 8.27 x |
P/E ratio 2025 * |
82.4
x | P/E ratio 2026 * |
61.9
x | Employees | - |
Yield 2025 * |
0.04% | Yield 2026 * |
0.27% | Free-Float | 99.41% |
Latest transcript on Xero Limited
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-11-27 | |
Director of Finance/CFO | - | 16-03-09 | |
Diya Jolly
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian McAndrews
BRD | Director/Board Member | 65 | 22-02-01 |
Anjali Joshi
BRD | Director/Board Member | 63 | 23-07-02 |
David Thodey
CHM | Chairman | 70 | 19-06-26 |
1st Jan change | Capi. | |
---|---|---|
-11.69% | 235B | |
+3.27% | 60.22B | |
-0.39% | 51.54B | |
-1.85% | 39.63B | |
+2.79% | 37.53B | |
-10.61% | 28.03B | |
+103.79% | 25.68B | |
+1.18% | 21.27B | |
+4.45% | 13.95B |
- Stock Market
- Equities
- XRO Stock
- XRO Stock